Advanced MRI Techniques for Epilepsy
Trial Summary
What is the purpose of this trial?
This project will test the accuracy of a novel diffusion-weighted magnetic resonance imaging (DWMRI) approach using a deep convolutional neural network (DCNN) to predict an optimal resection margin for pediatric epilepsy surgery objectively. Its primary goal is to minimize surgical risk probability (i.e., functional deficit) and maximize surgical benefit probability (i.e., seizure freedom) by precisely localizing eloquent white matter pathways in children and adolescents with drug-resistant focal epilepsy. This new imaging approach, which will acquire a DWMRI scan before pediatric epilepsy surgery in about 10 minutes without contrast administration (and also without sedation even in young children), can be readily applied to improve preoperative benefit-risk evaluation for pediatric epilepsy surgery in the future. The investigators will also study how the advanced DWMRI-DCNN connectome approach can detect complex signs of brain neuronal reorganization that help improve neurological and cognitive outcomes following pediatric epilepsy surgery. This new imaging approach could benefit targeted interventions in the future to minimize neurocognitive deficits in affected children. All enrolled subjects will undergo advanced brain MRI and neurocognitive evaluation to achieve these goals. The findings of this project will not guide any clinical decision-making or clinical intervention until the studied approach is thoroughly validated.
Will I have to stop taking my current medications?
The trial does not specify whether participants need to stop taking their current medications. It focuses on advanced MRI techniques and does not mention any medication changes.
What data supports the effectiveness of the treatment Brain Magnetic Resonance Imaging (MRI) for epilepsy?
Recent advances in MRI techniques, such as functional MRI and diffusion imaging, have improved the ability to identify and evaluate epileptogenic lesions, which are areas in the brain that cause seizures. These developments help in the presurgical evaluation and management of epilepsy, making MRI a crucial tool in diagnosing and planning treatment for patients with epilepsy.12345
Is MRI safe for humans?
MRI is generally considered safe for humans, with no long-term harmful effects from the magnetic fields and radio waves used. However, there are risks if safety guidelines are not followed, such as interference with electronic devices like pacemakers and potential burns from certain equipment. Proper screening and preparation are essential to ensure safety during MRI procedures.678910
How is the treatment 'Advanced MRI Techniques for Epilepsy' different from other treatments for epilepsy?
Advanced MRI techniques for epilepsy are unique because they provide detailed images of the brain's structure and function, helping to identify the specific areas involved in seizures. These techniques, such as diffusion-weighted imaging and MR spectroscopy, offer insights into the brain's microanatomy and chemical composition, which can aid in diagnosis and treatment planning, unlike traditional imaging methods.1251112
Eligibility Criteria
This trial is for children and adolescents aged 3-19 with drug-resistant focal epilepsy who are planning to undergo a specific two-stage surgery, as well as healthy controls aged 5-19. Participants must not have claustrophobia, pervasive developmental or psychiatric conditions predating seizures, significant brain malformations, history of prematurity or hypoxic-ischemic events, hemiplegia, dysmorphic syndromes, or excessive head motion during MRI.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Evaluation
Participants undergo advanced brain MRI and neurocognitive evaluation to assess preoperative conditions
Surgery and Immediate Postoperative Assessment
Participants undergo epilepsy surgery and immediate postoperative assessment using DCNN tract classification
Follow-up
Participants are monitored for safety and effectiveness, including neurocognitive outcomes, after surgery
Treatment Details
Interventions
- Brain Magnetic Resonance Imaging
Brain Magnetic Resonance Imaging is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Diagnostic imaging for various conditions including epilepsy
- Diagnostic imaging for various conditions including epilepsy
- Diagnostic imaging for various conditions including epilepsy
- Diagnostic imaging for various conditions including epilepsy
- Diagnostic imaging for various conditions including epilepsy
- Diagnostic imaging for various conditions including epilepsy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wayne State University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator